IL9R
Interleukin-9 receptor
Also known as: CD129, IL9R_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01113
- Gene
- IL9R
- Ensembl
- ENSG00000124334
- Chromosome
- X
- Canonical length
- 521 aa
- Protein class
- CD markers, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a cytokine receptor that specifically mediates the biological effects of interleukin 9 (IL9). The functional IL9 receptor complex requires this protein as well as the interleukin 2 receptor, gamma (IL2RG), a common gamma subunit shared by the receptors of many different cytokines. The ligand binding of this receptor leads to the activation of various JAK kinases and STAT proteins, which connect to different biologic responses. This gene is located at the pseudoautosomal regions of X and Y chromosomes. Genetic studies suggested an association of this gene with the development of asthma. Multiple pseudogenes on chromosome 9, 10, 16, and 18 have been described. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
521 residues, UniProt reviewed canonical sequence.
>Q01113|IL9R
1 MGLGRCIWEG WTLESEALRR DMGTWLLACI CICTCVCLGV SVTGEGQGPR SRTFTCLTNN
61 ILRIDCHWSA PELGQGSSPW LLFTSNQAPG GTHKCILRGS ECTVVLPPEA VLVPSDNFTI
121 TFHHCMSGRE QVSLVDPEYL PRRHVKLDPP SDLQSNISSG HCILTWSISP ALEPMTTLLS
181 YELAFKKQEE AWEQAQHRDH IVGVTWLILE AFELDPGFIH EARLRVQMAT LEDDVVEEER
241 YTGQWSEWSQ PVCFQAPQRQ GPLIPPWGWP GNTLVAVSIF LLLTGPTYLL FKLSPRVKRI
301 FYQNVPSPAM FFQPLYSVHN GNFQTWMGAH GAGVLLSQDC AGTPQGALEP CVQEATALLT
361 CGPARPWKSV ALEEEQEGPG TRLPGNLSSE DVLPAGCTEW RVQTLAYLPQ EDWAPTSLTR
421 PAPPDSEGSR SSSSSSSSNN NNYCALGCYG GWHLSALPGN TQSSGPIPAL ACGLSCDHQG
481 LETQQGVAWV LAGHCQRPGL HEDLQGMLLP SVLSKARSWT FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL9R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 4 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 4 nTPM
- thymus: 3.1 nTPM
- lymph node: 2.3 nTPM
- tonsil: 2.1 nTPM
- spleen: 1.7 nTPM
- small intestine: 1.6 nTPM
Single-cell type
- mast cells: 15 nCPM
- t-cells: 6.5 nCPM
- innate lymphoid cells: 5.8 nCPM
- nk-cells: 3.9 nCPM
- thymocytes: 3.4 nCPM
- hematopoietic stem cells: 1.9 nCPM
Immune cell
- eosinophil: 3.5 nTPM
- naive B-cell: 1.9 nTPM
- T-reg: 1.4 nTPM
- neutrophil: 1 nTPM
- memory B-cell: 0.9 nTPM
- memory CD8 T-cell: 0.6 nTPM
Brain region
- basal ganglia: 0.8 nTPM
- amygdala: 0.7 nTPM
- cerebral cortex: 0.7 nTPM
- hippocampal formation: 0.7 nTPM
- spinal cord: 0.6 nTPM
- thalamus: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.87
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.27
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
OntologyGO
Biological processes
- immunoglobulin mediated immune response
- interleukin-9-mediated signaling pathway
- regulation of cell population proliferation
- signal transduction
Molecular functions
- interleukin-9 binding
- interleukin-9 receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL9R in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL9R as an antibody target. Whether an autoantibody or antibody against IL9R could matter depends on whether native IL9R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL9R is annotated at the cell surface, where native IL9R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL9R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...